bearish
Cansino Biologics Placement - Past Deal Didn't Do Well, Losing the Vaccine Race
412 Views10 Dec 2020 20:06
Lilly Asia is looking to raise around US$180m via selling a 6% stake in CanSino Biologics Inc (6185 HK)'s H-shares. Lilly Asia last sold its stake in Apr 2020,
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
x